Blinatumomab in Acute Lymphoblastic Leukemia
1 Views
administrator
06/15/23
In this segment, Dan Douer, MD, and Mark R Litzow, MD, describe the novel immunotherapy agent, blinatumomab.
-
Category
Show more
Facebook Comments
No comments found